IP Verse

Cantargia competitive analysis

Loading summary...

Latest patents of Cantargia opposed by its competitors

Explore Cantargia's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3293202
Feb 7, 2024Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses Thereof3
EP3020730
Dec 26, 2018Anti-Il1Rap Antibodies And Their Use For Treating Human1

Latest publications and patents of Cantargia New

Explore the latest publications and patents granted to Cantargia, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Cantargia

EP3293202
Feb 7, 2024Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses ThereofPatent Maintained As Amended
EP3020730
Dec 26, 2018Anti-Il1Rap Antibodies And Their Use For Treating HumanOpposition Rejected

Latest PTAB cases involving Cantargia

Discover the latest PTAB cases involving Cantargia, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Cantargia with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CANTARGIA - 4 - -
BLUEFIN BIOMEDICINE1 - - -
ICHNOS SCIENCES1 - - -
MAB DISCOVERY1 - - -